Tsakos Energy Navigation Limited
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Nikolas Tsakos
- Full Time Employees
- 77
- Sector
- Energy
- Industry
- Oil & Gas Midstream
- Address
- Megaron Makedonia Athens GI Greece 175 64
- IPO Date
- Mar 5, 2002
- CIK
- 0001166663
- Website
- tenn.gr
- Similar Companies
- Business
- Tsakos Energy Navigation Limited (TEN) operates as an international shipping company focused on the transportation of crude oil, refined petroleum products, and liquefied natural gas. The company owns and operates a diversified fleet of modern, high-quality crude tankers, product tankers, and LNG carriers; it also engages in the chartering of these vessels on long-term, medium-term, and spot voyages to major oil companies, oil traders, and refiners worldwide. TEN provides technical management services for its vessels, including crew management, maintenance, and safety compliance, through its subsidiary Tsakos Technitrol Ltd.; additionally, it offers vessel acquisition, construction supervision, and sale services via Tsakos Marine Consultants Ltd. Founded in 1993 and headquartered in Athens, Greece, TEN serves global energy markets across key trading routes in the Atlantic Basin, Mediterranean, Middle East Gulf, West Africa, and Asia-Pacific regions, with a customer base comprising international oil majors and independent charterers. The company operates through segments including tanker operations, LNG operations, and management services, targeting spot and time charter contracts to optimize fleet utilization and revenue stability. Its fleet, managed from offices in Greece, the United States, United Kingdom, and Liberia, emphasizes eco-friendly vessels equipped with scrubbers, ballast water treatment systems, and low-emission engines to meet stringent environmental regulations. In recent developments, TEN expanded its fleet in 2024-2025 through the acquisition of two eco-designed LR1 product tankers and one suezmax tanker, bolstering its capacity in response to rising global energy demand; the company also secured a strategic long-term charter for a newbuild LNG dual-fuel suezmax tanker with an oil major, extending revenue visibility. TEN completed a significant debt refinancing in late 2024, issuing $150 million in senior unsecured notes to strengthen its balance sheet amid volatile freight rates. Furthermore, the company announced partnerships for vessel retrofits to LNG propulsion in early 2025, aligning with decarbonization goals, and reported robust Q3 2025 earnings driven by strong tanker utilization.
Company News
TEN Ltd. Announces Sale of Two First-Generation Suezmax Tankers
Tsakos Energy Navigation: Buy Before Earnings
TEN Ltd. Announces Date for the Second Quarter and Six Months 2026 Results, Conference Call and Webcast
Tsakos Energy Navigation (NYSE:TEN) versus Hermitage Offshore Services (OTCMKTS:HOFSQ) Critical Contrast
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
TEN Ltd. Announces Delivery and Naming of the Third in a Series of Twelve DP2 Shuttle Tankers Ordered at Samsung Heavy Industries, South Korea
Tsakos Energy Navigation (NYSE:TEN) Stock Passes Above 200 Day Moving Average – Here’s Why
Navigating the Future of Shipping: Leadership Insights – Q2 2026
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
TEN Ltd. Announces Second LNG Carrier Order in Hyundai Heavy Industries
TEN Ltd. Declares Common Stock Dividend
Tsakos Energy Navigation: There Is Still Some Upside, But Investors Are Quite Cautious
TEN Ltd. Holds Its Thirty-Third Annual General Meeting of Shareholders
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
A Look at Tsakos Energy Navigation Ltd (TEN) After 5.2% Decline -- GF Value $22.21 vs Price $38.01
Tsakos Energy Navigation Limited (TEN) Q1 2026 Earnings Call Transcript
Tsakos Energy Navigation Q1 Earnings Call Highlights
TEN, Ltd. Reports Profits for First Quarter 2026 and Declares Second Semi-Annual Common Share Dividend of $1.00